MENLO PARK, Calif., Aug. 27, 2013 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC ), a materials science company that develops and markets innovative and patented products for healthy living applications in food and biomedical markets, has engaged Liolios Group to provide investor relations and financial communications services.
Liolios Group will work closely with Landec's management to introduce the company to new institutional investors, analysts and key influencers in the financial community, including scheduling meetings, roadshow presentations, and investment conferences.
Gary Steele, Landec Chairman and CEO, commented: "Liolios brings proven experience for increasing investor awareness for companies such as Landec. Partnering with Liolios, we look forward to broadening our investor relations contacts in the financial community. The growth in revenues and net income at Landec over the past several years is a result of our strategic focus on investing in our two core businesses, the Apio food business and the Lifecore biomedical business. Both Apio and Lifecore develop and market innovative products for healthy living applications, supported by proprietary processes and patented products that have been developed from our underlying expertise in materials science. At Landec, our strategy is to continue to invest in these two businesses and drive growth through new product introductions, further advancing the existing leadership and market share positions held by Apio and Lifecore. As our business continues to evolve and grow, we value collaborating with Liolios to broaden awareness about Landec in the investment community."
About Liolios Group Inc.
Liolios Group, Inc. is a highly selective and comprehensive investor relations firm specializing in micro to mid-cap public companies. Liolios Group aims to deliver superior performance in corporate messaging and positioning, investor awareness, analyst and financial press coverage, and capital attraction. Founded in 1996 in Newport Beach, California, Liolios Group's senior partners each have more than 16 years of experience in finance and investments, and have represented more than 120 companies in a wide range of industries, including life sciences/healthcare, consumer/internet retail, business services, financials, digital, media/software, clean technology, technology, natural resources and special situations. For more information about Liolios Group, visit www.liolios.com .
About Landec Corporation
Landec Corporation is a materials science company that leverages its proprietary polymer technologies, application development and innovation capabilities to develop and commercialize new products in food and biomaterials markets. Landec's subsidiary, Apio , has become the leader in US fresh-cut specialty packaged vegetables sold in North America based on combining Landec's proprietary food packaging technology and the strength of two major national brands, Eat Smart® and GreenLine®, with the capabilities of large scale processing and national distribution. Lifecore Biomedical , a subsidiary of Landec, is a premium supplier of hyaluronan-based materials and medical products to ophthalmic, orthopedic and veterinary markets worldwide. In addition, Lifecore Biomedical provides specialized aseptic fill and finish services in a cGMP validated manufacturing facility for supplying commercial, clinical and pre-clinical products. Landec will also periodically work with market-leading companies to develop and commercialize differentiated polymer-based products under R&D and royalty agreements. For more information about the Company, visit Landec's website at www.landec.com .
Landec Corporation Gregory S. Skinner Vice President Finance and CFO (650) 261-3677 Investor Relations Contact: Liolios Group, Inc. Justin Vaicek Tel (949) 574-3860
